{
    "ucits": true,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Daily rebalancing, Compounding effect, Derivative use for leverage",
    "classification": "complex",
    "supporting_data": "The product is a 5x leveraged ETP on the Nasdaq-100 index, aiming to deliver 5 times the daily performance of the index. It uses derivatives to achieve this leverage, which is integral to its investment objective, not merely for efficient portfolio management. The product documentation explicitly states the presence of leverage (5x), daily rebalancing, and a compounding effect that can significantly alter returns over periods longer than one day. The product is classified as a Collateralised Exchange Traded Security (ETP), not a UCITS ETF, and it carries a highest risk class (7/7). The use of derivatives and leverage, combined with the synthetic nature of the replication (derivative-based exposure rather than physical holding), introduces complex risks such as counterparty risk, collateral risk, and the difficulty for retail investors to understand the payoff and risk profile. According to MiFID II rules and ESMA guidance, such features make the product complex, requiring an appropriateness assessment before sale to retail clients. The product also carries a mandatory comprehension alert in its KID, indicating it is not simple and may be difficult to understand. Therefore, despite being an exchange traded product, it is not a UCITS ETF and is complex under MiFID II criteria due to leverage, derivative use, synthetic replication, and complexity of payoff structure."
}